New York, NY – July 6, 2017 – New MainStream Capital (NMS) has announced a strategic investment in Omni Ophthalmic Management Consultants, LLC, also known as Omni Eye Services, partnering with its esteemed founders, Drs. Christopher Quinn, Douglas Grayson, Burton Wisotsky, and Michael Veliky. This investment aims to bolster Omni Eye Services’ practice management capabilities for Omni Eye Specialists P.A. (OES) and, pending necessary approvals, facilitate the acquisition of a majority stake in Essex Specialized Surgical Institute, LLC (ESSI). NMS’s investment will support Omni Eye Services alongside existing management, providing substantial capital for strategic acquisitions, new office expansions, recruitment of top-tier providers, and infrastructure enhancements, solidifying Omni’s position in the competitive eye care market.
Omni Eye Services, established in 1998, has become a premier optometric referral practice renowned for its comprehensive suite of specialty services. Focusing on advanced treatments for a wide spectrum of eye diseases, Omni operates a network of six strategically located offices across New Jersey and New York. Notably, this network includes a state-of-the-art ophthalmology-focused ambulatory surgery center. Staffed by over 26 board-certified ophthalmologists and residency-trained optometrists, and supported by a dedicated team of over 150 registered nurses, ophthalmic and surgical technicians, and patient service representatives, Omni Eye Services delivers exceptional care to over 75,000 patients annually.
Dr. Christopher Quinn, President of Omni Eye Services, expressed enthusiasm about the partnership, stating, “NMS is the ideal capital and strategic partner for Omni, bringing deep knowledge of the ophthalmology sector, extensive healthcare experience, and a truly collaborative partnership approach. This collaboration with NMS offers an exciting opportunity for Omni Eye Services and our dedicated employees to work alongside an experienced investment firm. Together, we aim to further enhance the leading practice we have diligently built. I am confident that NMS’s expertise will enable us to accelerate our growth trajectory, both organically and through strategic acquisitions, and to significantly expand the resources we offer to our patients and our network of optometric physician partners.”
Martin E. Chavez, Managing Partner at NMS, commented on the investment, “We are delighted to partner with the exceptional team at Omni Eye Services. Our investment in Omni perfectly illustrates NMS’s theme-driven strategy, which focuses on identifying outstanding opportunities in key sectors through in-depth research and strategic thesis development. Having closely evaluated numerous ophthalmology groups, we firmly believe that Omni’s founders and management team have cultivated a truly exceptional organization. Their unwavering commitment to superior patient care, delivered through a well-established co-management model, is truly commendable. We are eager to collaborate with the Omni team to further build upon their already leading platform in New Jersey and New York, expanding their reach and enhancing their service offerings.”
Luis Gonzalez, Partner at NMS, further elaborated on the market dynamics, “The eye care market presents a significant opportunity for consolidation, driven by a large and growing addressable market fueled by the aging U.S. population, coupled with a growing demand for specialized ophthalmological services and increasing shortages of ophthalmologists. This investment underscores our firm commitment to supporting entrepreneurial physicians by providing the necessary capital and strategic resources to accelerate growth, expand access to high-quality care, and ultimately improve patient outcomes within the evolving healthcare landscape.”
Greenberg Traurig provided legal counsel to NMS for this transaction. Omni Eye Services received financial advisory services from Cross Keys Capital, and legal counsel from McDermott Will & Emery.
About Omni Eye Services
Omni Eye Services is a leading optometric referral practice committed to providing advanced treatment for a comprehensive range of eye diseases. Based in Iselin, NJ, Omni distinguishes itself by not offering primary care optometric services. Instead, Omni strategically fosters a collaborative partnership between optometry and ophthalmology, ensuring patients receive exceptional, specialized vision care. Since its inception in 1998, Omni Eye Services has expanded its reach through a network of six offices spanning New Jersey and New York. This network includes an advanced ophthalmology-focused ambulatory surgery center, enhancing its capacity to deliver cutting-edge surgical eye care. With a dedicated team of over 26 board-certified ophthalmologists and residency-trained optometrists, and a support staff exceeding 150 professionals, Omni Eye Services manages over 75,000 patient encounters annually, demonstrating its significant impact on vision care in the region.
For more detailed information about Omni Eye Services, please visit their website at www.omnieyeservices.com.
About New MainStream Capital
New MainStream Capital (NMS) is a prominent private investment firm headquartered in New York. NMS specializes in strategic equity investments and leveraged buyouts, focusing on lower middle market companies poised for growth. The firm’s origins trace back to a spin-out from the Goldman Sachs Merchant Banking Division, establishing a strong foundation in investment expertise. NMS strategically targets companies within the U.S. that are positioned to capitalize on sustainable growth trends, with a particular emphasis on companies in the Healthcare Services and Specialized Business Services sectors. NMS is dedicated to partnering with management teams to drive long-term value creation and operational excellence.
For additional information on New MainStream Capital, please visit the firm’s website at nms-capital.com.
Contacts:
Dr. Christopher Quinn
President
Omni Eye Services
(732) 510 2554
www.omnieyeservices.com
David M. Peterson
Principal
New MainStream Capital
(212) 422-7099
nms-capital.com
